Login / Signup

PharmaPulse: new trial evidence from the HFA/ESC Heart Failure Congress 2021.

Peter Moritz BecherGianluigi Savarese
Published in: European heart journal. Cardiovascular pharmacotherapy (2022)
Keyphrases
  • heart failure
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • left ventricular
  • acute heart failure
  • atrial fibrillation
  • cardiac resynchronization therapy
  • open label